INS and diabetes mellitus: Moreover, a meta-regression analysis of randomized controlled trials comparing intensive blood glucose control obtained with conventional diabetes therapy (mainly insulin) with a less intensive regimen showed limited benefit of intensive glycemic control in people with type 2 diabetes and myocardial infarction, with a significant risk of serious hypoglycemia [39].